Delivered-To: bruce@untroubled.org
Received: (fqmail 710 invoked from network); 07 Jan 2014 18:45:19 -0000
Received: (qmail 2905 invoked from network); 7 Jan 2014 18:45:19 -0000
Received: from wind.zerodserver.com (wind.zerodserver.com [195.88.14.240])
  by mx11.futurequest.net ([10.2.1.184])
  with ESMTP via TCP; 07 Jan 2014 18:45:18 -0000
To: bruce@untroubled.org
Subject: NVLX Marijuana Research Could Lead to Many Successes
Message-ID: <2e02bd7cd5c4e6b77407e0caa6444cae@wind.zerodserver.com>
Return-Path: agency@wind.zerodserver.com
Date: Tue, 07 Jan 2014 12:44:47 -0600
From: "Inv. News" <agency@wind.zerodserver.com>
Reply-To: agency@wind.zerodserver.com
MIME-Version: 1.0
X-Mailer-LID: 19,573
List-Unsubscribe: <http://wind.zerodserver.com/unsubscribe.php?M=4198503&C=da3fb1d1d4bfdc21f17ccb7d32402084&L=573&N=7153>
X-Mailer-RecptId: 4198503
X-Mailer-SID: 7153
X-Mailer-Sent-By: 1
Content-Type: multipart/alternative; charset="UTF-8"; boundary="b1_05da70d9a235c6ff4473ff5cdd1f95c7"
Content-Transfer-Encoding: 8bit
Content-Length: 13672

--b1_05da70d9a235c6ff4473ff5cdd1f95c7
Content-Type: text/plain; format=flowed; charset="UTF-8"
Content-Transfer-Encoding: 8bit

Nuvilex, Inc. OTCQB: NVLX

Nuvilex, Inc.'s (NVLX) Marijuana Research into Cannabidiol Could Lead to
Many Successes Nuvilex, Inc. (OTCBQ: NVLX) formed its subsidiary, Medical
Marijuana Sciences, Inc., to study the medical applications of marijuana,
and more specifically, it has chosen to focus its initial research on
utilizing cannabidiol, or CBD, one of the compounds found in Cannabis, as
the basis for developing treatments for serious and deadly forms of cancer.
The company wants to use its expertise, current research and its success in
the biotechnology sector to make it among the leaders in the medical
marijuana industry.

Nuvilex's COO, Dr. Gerald Crabtree, said of the decision to focus the
company's research on CBD, "The decision was made to base those treatments
on cannabidiol rather than the more well-known cannabinoid,
tetrahydrocannabinol, to avoid any of the psychoactive properties that are
associated with tetrahydrocannabinol, but that are not present with CBD,
when such cancer treatments are developed."

When CNN chief medical correspondent Dr. Sanjay Gupta made his documentary
on the subject, it highlighted a number of cases where medical marijuana
has made a difference in the lives of patients suffering from a number of
ailments. In Gupta's yearlong travels to shape his own opinion in the
debate on marijuana's contribution to medicine, he learned that cannabidiol
could likely shape the greatest future successes using the med. The use of
research materials distributed by the author is done at your own risk. You
are encouraged to do your own research before making any investment
decision in regards to the security discussed herein. The author has not
been rewarded by any entity in connection with the disbursement of these
materials. You should presume that as of the date of this report or letter,
the author, possibly along with or through our owners, affiliates,
employees and/or consultants, (communally referred to as the author) has a
position in all company shares (and/or options of the shares) covered
herein that is consistent with the position set forth in our report. In
connection with NVLX, the author has taken a long position. Following the
distribution of any report or letter, the author intends to continue
engaging in transactions in the security covered herein, and we may be
long, short, and/or neutral at any time hereafter regardless of our initial
position and we preserve the right to procure or trade all or part of our
position at any time without notice. This practice could end in our trading
securities at any time before, during, and/or after the disbursement of
this report.

The Stock Group. All Rights Reserved.
You are receiving this because you have been subscribed to our list with
bruce@untroubled.org. If you wish to no longer receive our company updates
then please unsubscribe
[http://wind.zerodserver.com/unsubscribe.php?M=4198503&C=da3fb1d1d4bfdc21f17ccb7d32402084&L=573&N=7153].

--b1_05da70d9a235c6ff4473ff5cdd1f95c7
Content-Type: text/html; charset="UTF-8"
Content-Transfer-Encoding: 8bit

<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>

<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<meta name="viewport" content="width=device-width; initial-scale=1.0;
maximum-scale=1.0;" />
<title>NVLX</title>
<style type="text/css">
div, p, a, li, td  -webkit-text-size-adjust:none;

 .ReadMsgBody
width: 100%; background-color: #ffffff;
 .ExternalClass
width: 100%; background-color: #ffffff;
body
width: 100%; background-color: #ffffff; margin:0; padding:0;
-webkit-font-smoothing: antialiased;
html
width: 100%;


@media only screen and (max-width: 640px)

	body{ width:auto!important;

  .BoxWrap  width:440px !important;
  .RespoShadow  width:440px !important; height:60px !important;
  .RespoImage1  width:440px !important; height:440px !important;
  .RespoImage2  width:440px !important; height:220px !important;
	.RespoListMedium  width:340px !important;

  .RespoHideMedium  display:none !important;
  .RespoShowMedium  display:block !important;
  .RespoCenterMedium  text-align:center !important;
}

@media only screen and (max-width: 479px)

  body{width:auto!important;

  .BoxWrap  width:280px !important;
  .RespoShadow  width:280px !important; height:60px !important;
  .RespoImage1  width:280px !important; height:280px !important;
  .RespoImage2  width:280px !important; height:140px !important;
	.RespoLogo width: 100%!important; padding-left:0!important;
padding-right:0!important
	.RespoListSmall  width:180px !important;
	.RespoTimerSmall  font-size:33px!important; padding-left:5px!important;
padding-right:5px!important

  .RespoHideSmall  display:none !important;
  .RespoCenterSmall  text-align:center !important;
}

body
	background-color: #434343
	margin: 0px;
	padding: 0px;
	text-align: center;
	width: 100%;


 .BackgroundColor

 background-color: #434343;


 .ContentBlockColor

background-color: #ffffff;


 .SecondaryContentBlock

background-color: #f6f1ed;


 .subtitle  font-family: Georgia, Helvetica, Arial, sans-serif; font-size:
22px; font-weight: bold; font-style: normal; color: #5c5146; line-height:
22px; text-align: left;

img
	border:0px;
	outline:none;
	text-decoration:none;
	display:block;


a img
	border: none;


</style>
</head>

<body style="background-color: #434343; text-align:center;">
<table align="center" cellpadding="0" cellspacing="0"
class="BackgroundColor" style="width: 100%; background-color: #434343;
text-align: center;">
<tbody>
<tr>
<td valign="top">
<table cellspacing="0" cellpadding="0" style="width: 100%;">
<tbody>
<tr>
<td width="100%" class="BackgroundColor" height="15"></td>
</tr>
</tbody>
</table>
<table class="BoxWrap ContentBlockColor" border="0" align="center"
cellpadding="0" cellspacing="0" style="width: 600px; background-color:
#ffffff;">
<tbody>
<tr>
<td><!-- Caption -->
<table border="0" cellpadding="0" cellspacing="0" align="center"
style="width: 100%;">
<tbody>
<tr>
<td height="30"></td>
</tr>
<!-- // Horizontal Spacer \\ -->
<tr>
<td width="100%" style="padding-left: 30px; font-family: Georgia,
Helvetica, Arial, sans-serif; font-size: 34px; font-weight: bold;
font-style: normail; color: #473e36; line-height: 30px; text-align:
left;">Nuvilex, Inc.
<table bgcolor="#eb5d37" cellpadding="0" cellspacing="0" align="right"
border="0" style="width: 80px;">
<tbody>
<tr>
<td width="220" style="color: #ffffff; font-family: Georgia, Helvetica,
Arial, sans-serif; font-size: 32px; font-weight: bold; font-style: normal;
line-height: 28px; text-align: left; width: 220px; padding: 10px;">OTCQB:
NVLX</td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr>
<td height="30"></td>
</tr>
<!-- // Horizontal Spacer \\ --></tbody>
</table>
<!-- Number --><!-- Padding + (Outlook) --><!-- Text -->
<table cellpadding="0" cellspacing="0" align="center"
class="RespoListMedium RespoListSmall" border="0" style="width: 100%;
text-align: center;">
<tbody>
<tr>
<td width="100%" style="font-family: Helvetica, Arial, sans-serif;
font-size: 18px; font-weight: normal; color: #5c5146; line-height: 18px;
text-align: left; padding: 10px;"><strong>Nuvilex, Inc.&rsquo;s
(NVLX)</strong> Marijuana Research into Cannabidiol Could Lead to Many
Successes</td>
</tr>
</tbody>
</table>
<!-- Space --><!-- Number --><!-- Padding + (Outlook) --><!-- Text --><!--
Space --></td>
</tr>
</tbody>
</table>
</td>
</tr>
</tbody>
</table>
<table class="BoxWrap ContentBlockColor" align="center" cellpadding="0"
cellspacing="0" mc:repeatable="" style="width: 600px;">
<tbody>
<tr>
<td><!-- Space -->
<table border="0" cellpadding="0" cellspacing="0" align="center"
style="width: 100%;">
<tbody>
<tr>
<td class="SecondaryContentBlock" width="100%" height="2"></td>
</tr>
</tbody>
</table>
<!-- Number --><!-- Padding + (Outlook) --><!-- Text --><!-- Space
--></td>
</tr>
</tbody>
</table>
<table class="BoxWrap ContentBlockColor" align="center" cellpadding="0"
cellspacing="0" mc:repeatable="" style="width: 600px;">
<tbody>
<tr>
<td><!-- // First Column \\ --><!-- // Second Column \\ -->
<table class="BoxWrap" align="left" cellspacing="0" cellpadding="0"
style="width: 100%; background-color: #ffffff;">
<tbody>
<tr>
<td>
<table cellpadding="0" cellspacing="0" align="left" style="padding-left:
10px; padding-right: 10px; width: 100%;">
<tbody><!-- // Horizontal Spacer \\ -->
<tr>
<td width="100%" height="10"></td>
</tr>
<!-- // Horizontal Spacer \\ -->
<tr>
<td width="100%" style="text-align: left; font-family: Helvetica, Arial,
sans-serif; font-size: 14px; font-weight: normal; color: #5c5146;
line-height: 18px; padding: 10px;">Nuvilex, Inc. (OTCBQ:
<strong>NVLX</strong>) formed its subsidiary, Medical Marijuana Sciences,
Inc., to study the medical applications of marijuana, and more
specifically, it has chosen to focus its initial research on utilizing
cannabidiol, or CBD, one of the compounds found in Cannabis, as the basis
for developing treatments for serious and deadly forms of cancer. The
company wants to use its expertise, current research and its success in the
biotechnology sector to make it among the leaders in the medical marijuana
industry. <br /><br /> Nuvilex's COO, Dr. Gerald Crabtree, said of the
decision to focus the company's research on CBD, "The decision was made to
base those treatments on cannabidiol rather than the more well-known
cannabinoid, tetrahydrocannabinol, to avoid any of the psychoactive
properties that are associated with <span>tetrahydrocannabinol</span>, but
that are not present with CBD, when such cancer treatments are developed."
<br /><br /> When CNN chief medical correspondent Dr. Sanjay Gupta made his
documentary on the subject, it highlighted a number of cases where medical
marijuana has made a difference in the lives of patients suffering from a
number of ailments. In Gupta's yearlong travels to shape his own opinion in
the debate on marijuana&rsquo;s contribution to medicine, he learned that
cannabidiol could likely shape the greatest future successes using the
med.</td>
</tr>
<tr>
<td width="100%" height="20"></td>
</tr>
<!-- // Horizontal Spacer \\ --> <!-- // Horizontal Spacer \\ --></tbody>
</table>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr>
<td width="100%" class="BackgroundColor" height="15"></td>
</tr>
<!-- // Horizontal Spacer \\ --></tbody>
</table>
<table class="BoxWrap BackgroundColor" align="center" cellpadding="0"
cellspacing="0" mc:repeatable="" style="width: 600px;">
<tbody>
<tr>
<td><!-- // First Column \\ -->
<table class="BoxWrap ContentBlockColor" align="right" cellspacing="0"
cellpadding="0" style="padding: 30px; width: 100%;" border="0">
<tbody>
<tr>
<td>
<table bgcolor="#eb5d37" cellpadding="0" cellspacing="0" border="0"
style="width: 100%;">
<tbody><!-- // Horizontal Spacer \\ -->
<tr>
<td width="100%" height="15"></td>
</tr>
<tr>
<td height="15" bgcolor="#FFFFFF" style="background-color: #ffffff;
font-family: Helvetica, Arial, sans-serif; font-size: 12px; font-weight:
normal; color: #8e8071; line-height: 16px; padding: 10px;"><span>The use of
research materials distributed by the author is done at your own risk. You
are encouraged to do your own research before making any investment
decision in regards to the security discussed herein. The author has not
been rewarded by any entity in connection with the disbursement of these
materials. You should presume that as of the date of this report or letter,
the author, possibly along with or through our owners, affiliates,
employees and/or consultants, (communally referred to as the author) has a
position in all company shares (and/or options of the shares) covered
herein that is consistent with the position set forth in our report. In
connection with NVLX, the author has taken a long position. Following the
distribution of any report or letter, the author intends to continue
engaging in transactions in the security covered herein, and we may be
long, short, and/or neutral at any time hereafter regardless of our initial
position and we preserve the right to procure or trade all or part of our
position at any time without notice. This practice could end in our trading
securities at any time before, during, and/or after the disbursement of
this report.</span></td>
</tr>
<!-- // Horizontal Spacer \\ --> <!-- // Horizontal Spacer \\ --></tbody>
</table>
</td>
</tr>
</tbody>
</table>
<!-- // Second Column \\ --></td>
</tr>
<tr>
<td width="100%" class="BackgroundColor" height="15" style="font-family:
Helvetica, Arial, sans-serif; font-size: 12px; font-weight: normal; color:
#91877e; line-height: 16px; text-align: center;"><br /> The Stock Group.
All Rights Reserved.<br /> You are receiving this because you have been
subscribed to our list with bruce@untroubled.org. If you wish to no longer
receive our company updates then please <a
href="http://wind.zerodserver.com/unsubscribe.php?M=4198503&C=da3fb1d1d4bfdc21f17ccb7d32402084&L=573&N=7153"
style="color: #ada7a1; text-decoration: underline;">unsubscribe</a>.</td>
</tr>
<!-- // Horizontal Spacer \\ --></tbody>
</table>
<table class="BoxWrap ContentBlockColor" align="center" cellpadding="0"
cellspacing="0" mc:repeatable="" style="width: 600px;">
<tbody>
<tr></tr>
</tbody>
</table>
<table cellpadding="0" cellspacing="0" style="width: 100%;"></table>
<img
src="http://wind.zerodserver.com/open.php?M=4198503&L=573&N=7153&F=H&image=.jpg"
height="1" width="10"></body>
</html>

--b1_05da70d9a235c6ff4473ff5cdd1f95c7--
